News

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine
(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...
FDA approves Novavax's COVID-19 vaccine with limitations
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
FDA approves Novavax COVID vaccine with new conditions
China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...
FDA approves Novavax COVID-19 vaccine, but with unusual restrictions on its use
In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about ...
F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Novavax jumps as FDA clears COVID-19 vaccine
Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from ...
Novavax Soars After Covid Vaccine Secures Full FDA Approval
Novavax Inc. jumped in early trading after US regulators fully approved its Covid vaccine, easing investors’ concerns after ...
U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics ...
BioSpace45m
FDA Grants Narrow Approval of Novavax’s COVID Shot as Makary Teases Changes to Vaccine Approval Framework
The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...
FDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage Restrictions
The Food and Drug Administration has granted full approval to Novavax, Inc. (NASDAQ:NVAX) COVID-19 vaccine, but with notable ...
Novavax shares surge on FDA vaccine approval
Investors reacted positively to the news, as the FDA’s approval not only enhances Novavax’s product offering but also solidifies its partnership with Sanofi, a key player in the vaccine market. The ...